Early Recovery of Left Ventricular Systolic Function After CoreValve Transcatheter Aortic Valve Replacement

Harold L Dauerman1, Michael J Reardon2, Jeffrey J Popma2

  • 1From the University of Vermont College of Medicine, Burlington (H.L.D); Houston DeBakey Heart and Vascular Center, The Houston Methodist Hospital, TX (M.J.R., S.H.L., N.S.K.); Beth Israel Deaconess Medical Center, Boston, MA (J.J.P.); University of Pittsburgh Medical Center, PA (J.L.C.); Mount Sinai School of Medicine, New York, NY (D.H.A.); and Mayo Clinic, Rochester, MN (J.K.O.). harold.dauerman@uvmhealth.org.

Insights

Transcatheter aortic valve replacement significantly improves left ventricular ejection fraction (LVEF) in many patients with reduced LVEF. Early LVEF recovery after TAVR is linked to better outcomes and is predicted by higher valve gradients and no prior heart attack.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Interventional Cardiology

Background:

  • Reduced left ventricular ejection fraction (LVEF) affects approximately one-third of patients with symptomatic aortic stenosis awaiting transcatheter aortic valve replacement (TAVR).
  • The early recovery of LVEF after TAVR, its predictors, and clinical significance remain underexplored.

Purpose of the Study:

  • To investigate the incidence and predictors of early LVEF recovery following CoreValve TAVR in patients with pre-existing reduced LVEF.
  • To assess the association between early LVEF recovery and one-year clinical outcomes.

Main Methods:

  • Analysis of 156 patients from the CoreValve Extreme and High-Risk trials with baseline LVEF ≤40% and available 30-day LVEF data.
  • Echocardiographic assessment of LVEF at multiple time points (baseline, post-procedure, discharge, 30 days, 6 months, 1 year).
  • Definition of early LVEF recovery as an absolute increase of ≥10% in EF at 30 days; multivariable analysis for predictor identification.

Main Results:

  • Early LVEF recovery was observed in 62% of patients, often occurring before hospital discharge.
  • The early recovery group showed a significant LVEF increase (>17%) by 30 days compared to the no-early recovery group (48.9±8.8% vs. 31.5±6.9%).
  • Absence of previous myocardial infarction and a baseline mean aortic valve gradient ≥40 mmHg were identified as independent predictors of early LVEF recovery.

Conclusions:

  • Nearly two-thirds of patients with reduced LVEF experience significant early improvement after TAVR.
  • Early LVEF recovery post-TAVR is associated with improved clinical outcomes.
  • Higher baseline aortic valve gradients and the absence of prior myocardial infarction are key predictors for early LVEF recovery.
Abstract

Related Concept Videos

Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
1.1K
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
892
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
540
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
824
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
512
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.2K